Next Article in Journal
Rituximab-Containing Risk-Adapted Treatment Strategy in Nodular Lymphocyte Predominant Hodgkin Lymphoma: 7-Years Follow-Up
Next Article in Special Issue
Meta-Analysis of Survival and Development of a Prognostic Nomogram for Malignant Pleural Mesothelioma Treated with Systemic Chemotherapy
Previous Article in Journal
Zona Pellucida Protein 2 (ZP2) Is Expressed in Colon Cancer and Promotes Cell Proliferation
Previous Article in Special Issue
Malignant Pleural Mesothelioma Interactome with 364 Novel Protein-Protein Interactions
 
 
Article

Article Versions Notes

Cancers 2021, 13(8), 1761; https://doi.org/10.3390/cancers13081761
Action Date Notes Link
article xml file uploaded 7 April 2021 12:03 CEST Original file -
article xml uploaded. 7 April 2021 12:03 CEST Update -
article pdf uploaded. 7 April 2021 12:03 CEST Version of Record https://www.mdpi.com/2072-6694/13/8/1761/pdf-vor
article supplementary file uploaded. 7 April 2021 12:03 CEST - https://www.mdpi.com/2072-6694/13/8/1761#supplementary
article html file updated 7 April 2021 12:04 CEST Original file -
article xml file uploaded 8 April 2021 08:02 CEST Update -
article xml uploaded. 8 April 2021 08:02 CEST Update -
article pdf uploaded. 8 April 2021 08:02 CEST Updated version of record https://www.mdpi.com/2072-6694/13/8/1761/pdf-vor
article html file updated 8 April 2021 08:04 CEST Update -
article xml file uploaded 9 April 2021 08:04 CEST Update -
article xml uploaded. 9 April 2021 08:04 CEST Update https://www.mdpi.com/2072-6694/13/8/1761/xml
article pdf uploaded. 9 April 2021 08:04 CEST Updated version of record https://www.mdpi.com/2072-6694/13/8/1761/pdf
article html file updated 9 April 2021 08:06 CEST Update -
article html file updated 4 August 2021 13:14 CEST Update -
article html file updated 25 July 2022 11:06 CEST Update https://www.mdpi.com/2072-6694/13/8/1761/html
Back to TopTop